Nā ʻŌlelo Aʻo
-
Kanaka & Holoholona Bile o Blank Biological Matrix for Bioanalytical Method Development and Bioanalytical Method Validation
Hua'ōlelo nui: blank biological analysis, biological matrix sample, biomatrix analysis, bile kanaka, bile holoholona, sample bile, bile artificial, bile simulated, bile NHP, bile monkey Cynomolgus, Rhesus MonkHeluhelu hou aku -
ʻO ka wai cerebrospinal fluid (CSF) matrix no ke keʻa-nā ʻano ʻano CNS hoʻāʻo lāʻau.
Hua'ōlelo: Cerebrospinal Fluid, Artificial Cerebrospinal Fluid, Artificial CSF, Simulated Cerebrospinal Fluid, CSF Simulated, CSF Sample, LC - MS / MS, CSF kanaka, Cynomolgus Monkey Cerebrospinal Fluid (CSF).Heluhelu hou aku -
5α-Reductase Haʻawina Haʻawina: SRD5A1 & SRD5A2 no ka Sebum Control ma Cosmetic Science
Hua'ōlelo: Type 1 5α-Reductase, Type 2 5α-Reductase, 5αR1, 5αR2, SRD5A1, SRD5A2, NADPH, 5α-Reductase Activity, 5α-Reductase Inhibition, Dihydrotestosterone(DHT).IPHHeluhelu hou aku -
Hoʻokomo ʻia i ka ʻiole Liver S9 Fraction: He Pūnaehana Hoʻōla Metabolic no ka In Vitro Genotoxicity a me ka hoʻāʻo ʻana.
Hua'ōlelo: OECD 471, OECD 473, OECD 476, OECD 487, Mutation Test, Genotoxicity, Genetic Toxicity, Induced Rat Liver S9, Ames Test, Mini Ames Test, Chromosomal Aberration, Micronucleus, HPRT/HGPRT AssayHeluhelu hou aku -
Plasma Protein Binding Dynamics: Equilibrium dialysis and Ultrafiltration Methods and Application in DDIs
Hua'ōlelo: Equilibrium Dialysis, Ultrafiltration, Plasma Protein Binding (PPB), Binding rate of plasma protein (BRPP), Equilibrium Dialysis Device, Equilibrium Dialysis Membrane, Rapid Equilibrium DialysHeluhelu hou aku -
Hepatocytes in Drug Metabolism and siRNA Drug Delivery: E loiloi ana i nā ʻōnaehana kumu hoʻohālike ma nā ʻano ʻano
Hua'ōlelo: Hepatocytes, Primary Hepatocytes, Plateable Hepatocytes, Suspension Hepatocytes, Hepatocytes Metabolic Stability, Hepatotoxicity, CYP450 Enzyme Induction, Primary HumanHepatocytes (PHH), PrimHeluhelu hou aku -
Nā Microsomes i ka Metabolic Stability Assays: Ke kuleana ma ka Phase I Metabolism a me ka Phase II Metabolism
IPHASE Biosciences ProductsInoa huahanaSpecificationLiver MicrosomesIPHASE Human Liver Microsomes,Mixed Gender0.5mL,20mg/mLIPHASE Monkey(Cynomolgus) Liver Microsomes,KaneHeluhelu hou aku -
Splenocytes in Immunological Research: Across Species and Isolation, Freezing, Thawing Steps
Hua'ōlelo: Splenocytes (SPLs); Cynomolgus Monkey Splenocytes; Rhesus Monkey Splenocytes; ʻīlio Splenocytes; Canine Splenocytes; Splenocytes Iole; Splenocytes iole; ʻIole Splenocytes; Lapi Splenocytes; SpHeluhelu hou aku -
Nā holomua i ka Bioanalysis: Ke kuleana o LC-MS/MS i ka hoʻomohala ʻana i nā lāʻau Ophthalmic a me nā haʻawina hoʻonaʻauao wai a me Vitreous.
Hua'ōlelo: Humor Aqueous Human, Monkey Aqueous Humor, Rabbit Aqueous Humor, Non-human Primate Aqueous Humor, Human Vitreous Humor, Monkey Vitreous Humor, Rabbit Vitreous Humor, Non-human Primate VitreoHeluhelu hou aku -
Ka Hoʻohālikelike Hoʻohālikelike o nā Pūnaewele Mononuclear Koko Keʻeʻe (PBMCs): Nā noi ma nā ʻano ʻano like ʻole i ka Immunology a me Therapeutic Research.
Nā Huahana IPHASE Inoa Huahana ManaʻoIPHASE Monkey(Cynomolgus) PBMC,Frozen5millionIPHASE Monkey(Rhesus) PBMC,Frozen5millionIPHASE Dog(Beagle) PBMC,Frozen5millionHeluhelu hou aku -
In Vitro Evaluation of In Vitro Drug Transporter: E ʻimi ana i nā kuleana o ABC Vesicles a me SLC Transporter Cells
Hua'ōlelo: ATP-paʻa cassette(ABC), ABC Transporter, SLC Transporter, Membrane Vesicle, MDR1(P-gp), BSEP, BCRP, MATE1, MATE2-K, OAT1, OATP1B1, MDCK II, Caco-2, Transporter Inhibition, Transporter SubHeluhelu hou aku -
Lysosomal Stability: He mea nui i ka ADC Linker Performance and siRNA Delivery for Enhanced Therapeutic Efficacy
Hua'ōlelo: ADC linker, Payload release, ate lysosome, lysosomal stability, lysosome catabolism, Cathepsin B, DS8201a, GGFG-DxD, GalNAc‑siRNA, siRNA Delivery, siRNA Escape, Hepatocyte Lysosomes, Tritosome, Phososomalse AcidHeluhelu hou aku